Johnson & Johnson (JNJ)
Johnson & Johnson Accounts Receivable: 10.98B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
JNJ Accounts Receivable Rankings
| Overall | 98th percentile | 45 of 3769 |
| Sector | 99th percentile | 2 of 442 in Healthcare |
| Industry | 88th percentile | 2 of 17 in Drug Manufacturers - Major |
JNJ Accounts Receivable Range, Past 5 Years
| Minimum | 9.384B | Sep 2007 |
| Maximum | 10.98B | Jun 2011 |
| Average | 10.13B |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
You may also be interested in these JNJ related companies
JNJ News
$JNJ 62.5x puts alerted last week at .72 before its drug news. Really killed the premium, just alerted to sell at .84. Small 16.7% gain.
about 5 hours ago by OptionRunners
about 5 hours ago by OptionRunners
Still a Bear Market http://stks.co/41w6 $CSCO $INTC $HPQ $IBM $JNJ $JPM
about 7 hours ago by LouisEbner
about 7 hours ago by LouisEbner
$JNJ broke the horizontal support, but within acceptable distance. V light maybe possible uptick is within a reach
about 22 hours ago by woowtrading
about 22 hours ago by woowtrading
J&J (JNJ) Receives FDA Warning Letter Related to K-Y Vaginal Moisturizer -WSJ
May 29, 1:57PM Street Insider
May 29, 1:57PM Street Insider
Five Stocks Hedge Funds are Betting Against: the Short List from Goldman Sachs http://stks.co/3zh7 $IBM $XOM $INTC $AMZN $JNJ
about 5 days ago by ycharts
about 5 days ago by ycharts
Current portfolio: $AAPL $AIG $JNJ $DD looking to add energy name soon
about 6 days ago by WestCoastHedge
about 6 days ago by WestCoastHedge
May 24 Support/resistance numbers for S&P and top components. http://stks.co/3y4b $ES_F $AAPL $XOM $CVX $JNJ $PG $$
about 6 days ago by TripleDTrader
about 6 days ago by TripleDTrader
Former Stryker (SYK) CEO Sends Strong Message to Other Execs: Ask First
May 23, 11:42AM Street Insider
May 23, 11:42AM Street Insider
Ex-Dividend Stocks http://stks.co/3wtm My story via @TheStreet $JNJ $MHP $AIZ $DNB $NDSN $WEP $SIX #Dividend #ExDividend
about 7 days ago by azendrian
about 7 days ago by azendrian
Go into Pharma to avoid the bloodbath in the markets. Rotation into safety $PFE $MRK $JNJ http://stks.co/3tbu
about 12 days ago by EPS_MomentuM
about 12 days ago by EPS_MomentuM
News related to $JNJ, currently 0.0% since open: 'Alkermes takes bigger 4Q loss after Elan deal' http://stks.co/3sOZ
about 13 days ago by TradeBot
about 13 days ago by TradeBot
Expectations Indicator triggered a Bear Market http://stks.co/3sJw $JNJ $JPM $KFT $MCD
about 13 days ago by LouisEbner
about 13 days ago by LouisEbner
RT @SeemaCnbc Cancer data expected to move big pharma $JNJ $PFE $AZN
about 13 days ago by StockTwits
about 13 days ago by StockTwits
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| JNJ | 62.21 | -0.38 | -0.61% | 171.83B |
| JMP | 5.87 | -0.05 | -0.84% | 130.60M |
| JMBA | 1.895 | -0.04 | -1.81% | 129.87M |
| JLS | 23.84 | -0.10 | -0.42% | |
| JLL | 72.17 | -2.07 | -2.79% | 3.239B |
| JKS | 3.91 | +0.01 | +0.26% | 87.20M |
| JKJ | 87.61 | -1.27 | -1.43% | |
| ISCA | 23.90 | -0.09 | -0.38% | 1.110B |
| ISBC | 14.76 | -0.24 | -1.60% | 1.672B |
| IRV | 21.82 | +0.45 | +2.11% |
